GlobalData on MSN7d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Yahoo Finance7d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement with buyer Clayton Dubilier & Rice (CD&R).
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Drug Store News7d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
Sanofi: Sanofi and CD&R sign Opella share purchase agreement
Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed ...
Daily5d
Sanofi nears selling 50 percent controlling stake in Opella to CD&R
Paris: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 ...
Nasdaq7d
Sanofi Signs Share Purchase Deal To Sell 50% Controlling Stake In Opella To CD&R
The valuation of Opella was then based on an enterprise value of 16 billion euros. Sanofi now said the agreement follows completion of the required social and corporate procedures. Bpifrance is ...